BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao Y, Tan W, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus 2008;21:139-43. [PMID: 18269649 DOI: 10.1111/j.1442-2050.2007.00746.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang B, Wang D, Zhang D, Li A, Liu D, Liu H, Jin H. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis. European Journal of Cancer Prevention 2010;19:299-307. [DOI: 10.1097/cej.0b013e32833964bc] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Piao JM, Shin MH, Kim HN, Song HR, Kweon SS, Choi JS, Shim HJ, Hwang JE, Bae WK, Kim SH, Choi YD, Cui LH. Replication of results of genome-wide association studies on esophageal squamous cell carcinoma susceptibility loci in a Korean population. Dis Esophagus 2014;27:798-801. [PMID: 24152165 DOI: 10.1111/dote.12155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
3 Zhao L, Zhao X, Wu X, Tang W. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies. Genet Test Mol Biomarkers 2013;17:721-6. [PMID: 23844939 DOI: 10.1089/gtmb.2013.0103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
4 Wang S, Pan D, Su M, Huang G, Sun G. Moderately high folate level may offset the effects of aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and precancerous lesions. Genes Nutr 2020;15:18. [PMID: 32993492 DOI: 10.1186/s12263-020-00677-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pan D, Su M, Huang G, Luo P, Zhang T, Fu L, Wei J, Wang S, Sun G. MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study. Cancer Cell Int 2019;19:288. [PMID: 31754346 DOI: 10.1186/s12935-019-1012-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Das M, Sharma SK, Sekhon GS, Mahanta J, Phukan RK, Jalan BK. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.Tumour Biol. 2017;39:1010428317698384. [PMID: 28459370 DOI: 10.1177/1010428317698384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
7 Adduri RS, Katamoni R, Pandilla R, Madana SN, Paripati AK, Kotapalli V, Bashyam MD. TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India. PLoS One 2014;9:e114002. [PMID: 25436609 DOI: 10.1371/journal.pone.0114002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer. 2011;129:920-930. [PMID: 20886596 DOI: 10.1002/ijc.25710] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
9 Bellini MF, Cadamuro AC, Succi M, Proença MA, Silva AE. Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomed Biotechnol. 2012;2012:891961. [PMID: 22919278 DOI: 10.1155/2012/891961] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
10 Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yoon JY, Chung IJ, Kim SH, Shin MH. p53 codon 72 polymorphism and the risk of esophageal cancer: a Korean case-control study. Dis Esophagus 2011;24:596-600. [PMID: 21595775 DOI: 10.1111/j.1442-2050.2011.01203.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
11 Katkoori VR, Manne U, Chaturvedi LS, Basson MD, Haan P, Coffey D, Bumpers HL. Functional consequence of the p53 codon 72 polymorphism in colorectal cancer. Oncotarget 2017;8:76574-86. [PMID: 29100333 DOI: 10.18632/oncotarget.20580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Malisic EJ, Jankovic RN, Jakovljevic KV, Radulovic SS. Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013;166:90-3. [DOI: 10.1016/j.ejogrb.2012.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H, Grizzle WE, Manne U. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res 2009;15:2406-16. [PMID: 19339276 DOI: 10.1158/1078-0432.CCR-08-1719] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
14 Wang S, Pan D, Zhang T, Su M, Sun G, Wei J, Guo Z, Wang K, Song G, Yan Q. Corn Flour Intake, Aflatoxin B1 Exposure, and Risk of Esophageal Precancerous Lesions in a High-Risk Area of Huai'an, China: A Case-Control Study. Toxins (Basel) 2020;12:E299. [PMID: 32384611 DOI: 10.3390/toxins12050299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Du L, Lei L, Zhao X, He H, Chen E, Dong J, Zeng Y, Yang J. The Interaction of Smoking with Gene Polymorphisms on Four Digestive Cancers: A Systematic Review and Meta-Analysis. J Cancer 2018;9:1506-17. [PMID: 29721061 DOI: 10.7150/jca.22797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Shao Y, Yu ZL, Ji M, Wu YD, Yu YZ, Liang XM, Yu LI, Niu YL, Li P, Zhang ST. Lugol chromoendoscopic screening for esophageal dysplasia/early squamous cell carcinoma in patients with esophageal symptoms in low-risk region in China. Oncol Lett 2015;10:45-50. [PMID: 26170975 DOI: 10.3892/ol.2015.3230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: A meta-analysis. World J Gastroenterol 2011; 17(9): 1227-1233 [PMID: 21448430 DOI: 10.3748/wjg.v17.i9.1227] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]